Alexandra Pedraza

511 total citations
17 papers, 223 citations indexed

About

Alexandra Pedraza is a scholar working on Hematology, Oncology and Transplantation. According to data from OpenAlex, Alexandra Pedraza has authored 17 papers receiving a total of 223 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 4 papers in Oncology and 4 papers in Transplantation. Recurrent topics in Alexandra Pedraza's work include Hematopoietic Stem Cell Transplantation (12 papers), Acute Myeloid Leukemia Research (4 papers) and Renal Transplantation Outcomes and Treatments (4 papers). Alexandra Pedraza is often cited by papers focused on Hematopoietic Stem Cell Transplantation (12 papers), Acute Myeloid Leukemia Research (4 papers) and Renal Transplantation Outcomes and Treatments (4 papers). Alexandra Pedraza collaborates with scholars based in Spain, Germany and Colombia. Alexandra Pedraza's co-authors include António Gil‐Nagel, Xiana Rodríguez‐Osorio, Laura Rosiñol, Carmen Martı́nez, Carlos Benavides, Francesc Fernández‐Avilés, María Suárez‐Lledó, Gonzalo Gutiérrez, Montserrat Rovira and María Queralt Salas and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancers.

In The Last Decade

Alexandra Pedraza

12 papers receiving 221 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexandra Pedraza Spain 8 88 63 53 39 35 17 223
Anna Jeong United States 12 73 0.8× 38 0.6× 27 0.5× 58 1.5× 34 1.0× 22 346
Nobuyoshi Sugiyama Japan 10 78 0.9× 55 0.9× 50 0.9× 51 1.3× 9 0.3× 28 342
Weihong Lin China 10 47 0.5× 38 0.6× 5 0.1× 17 0.4× 18 0.5× 30 285
Federica Ranzato Italy 9 100 1.1× 62 1.0× 8 0.2× 58 1.5× 23 0.7× 15 262
Muhammad Talal Alrifai Saudi Arabia 12 48 0.5× 53 0.8× 45 0.8× 47 1.2× 9 0.3× 28 444
Alessia De Nisco Italy 9 57 0.6× 25 0.4× 15 0.3× 26 0.7× 19 0.5× 20 295
Marios Kaliakatsos United Kingdom 12 114 1.3× 51 0.8× 6 0.1× 64 1.6× 48 1.4× 31 411
Francesco Habetswallner Italy 8 123 1.4× 111 1.8× 6 0.1× 45 1.2× 23 0.7× 24 264
Hideki Matsumura Japan 12 10 0.1× 17 0.3× 23 0.4× 75 1.9× 38 1.1× 33 404
Eleonora Mauri Italy 7 84 1.0× 40 0.6× 5 0.1× 50 1.3× 40 1.1× 22 332

Countries citing papers authored by Alexandra Pedraza

Since Specialization
Citations

This map shows the geographic impact of Alexandra Pedraza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandra Pedraza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandra Pedraza more than expected).

Fields of papers citing papers by Alexandra Pedraza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandra Pedraza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandra Pedraza. The network helps show where Alexandra Pedraza may publish in the future.

Co-authorship network of co-authors of Alexandra Pedraza

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandra Pedraza. A scholar is included among the top collaborators of Alexandra Pedraza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandra Pedraza. Alexandra Pedraza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Suárez‐Lledó, María, Luis Gerardo Rodríguez‐Lobato, Tommaso Francesco Aiello, et al.. (2025). Post-Transplant Cyclophosphamide-Based Prophylaxis and Its Impact on Infectious Complications and Immune Reconstitution According to Donor Type. Cancers. 17(7). 1109–1109.
2.
Tolosa, Carles, Luis Gerardo Rodríguez‐Lobato, Alexandra Pedraza, et al.. (2024). EASIX and cardiac adverse events after allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. 59(7). 974–982. 4 indexed citations
3.
Salas, María Queralt, Alexandra Pedraza, María Suárez‐Lledó, et al.. (2024). Reduced Dose of Post-Transplant Cyclophosphamide with Tacrolimus for the Prevention of Graft-versus-Host Disease in HLA-Matched Donor Peripheral Blood Stem Cell Transplants: A Prospective Pilot Study. Cancers. 16(14). 2567–2567. 3 indexed citations
4.
Suárez‐Lledó, María, Cristina Moreno, Joan Cid, et al.. (2024). Outcomes of older adults undergoing allogeneic hematopoietic cell transplantation with post‐transplant cyclophosphamide based prophylaxis. European Journal Of Haematology. 113(6). 765–775.
5.
6.
Pedraza, Alexandra, et al.. (2024). Follow-up of a Cohort of Patients with Secondary Erythrocytosis Due to Testosterone Treatment. Blood. 144(Supplement 1). 5216–5216.
7.
Pedraza, Alexandra, María Queralt Salas, Luis Gerardo Rodríguez‐Lobato, et al.. (2023). Easix Score Correlates With Endothelial Dysfunction Biomarkers and Predicts Risk of Acute Graft-Versus-Host Disease After Allogeneic Transplantation. Transplantation and Cellular Therapy. 30(2). 187.e1–187.e12. 22 indexed citations
8.
Salas, María Queralt, Alexandra Pedraza, María Suárez‐Lledó, et al.. (2023). Post-Transplantation Cyclophosphamide and Tacrolimus for Graft-versus-Host Disease Prevention after Allogeneic Hematopoietic Cell Transplantation from HLA-Matched Donors Has More Advantages Than Limitations. Transplantation and Cellular Therapy. 30(2). 213.e1–213.e12. 5 indexed citations
9.
Martínez-Sánchez, Julia, Marta Palomo, Alexandra Pedraza, et al.. (2023). Differential protein expression in endothelial cells exposed to serum from patients with acute graft‐vs‐host disease, depending on steroid response. Journal of Cellular and Molecular Medicine. 27(9). 1227–1238. 3 indexed citations
10.
Salas, María Queralt, Luis Gerardo Rodríguez‐Lobato, María Suárez‐Lledó, et al.. (2023). Applicability and validation of different prognostic scores in allogeneic hematopoietic cell transplant (HCT) in the post-transplant cyclophosphamide era. Hematology Transfusion and Cell Therapy. 46. S3–S12.
11.
Salas, María Queralt, Alexandra Pedraza, Núria Martínez‐Cibrián, et al.. (2022). PTCY and Tacrolimus for GVHD Prevention for Older Adults Undergoing HLA-Matched Sibling and Unrelated Donor AlloHCT. Transplantation and Cellular Therapy. 28(8). 489.e1–489.e9. 8 indexed citations
12.
Pedraza, Alexandra, María Queralt Salas, Luis Gerardo Rodríguez‐Lobato, et al.. (2022). Effect of CD34+ Cell Dose on the Outcomes of Allogeneic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide. Transplantation and Cellular Therapy. 29(3). 181.e1–181.e10. 8 indexed citations
13.
Salas, María Queralt, Gonzalo Gutiérrez, Gisela Riu-Viladoms, et al.. (2022). Impact of Early Intrapatient Variability of Tacrolimus Concentrations on the Risk of Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide. Pharmaceuticals. 15(12). 1529–1529. 7 indexed citations
14.
Pedraza, Alexandra, Sofía Jorge, María Suárez‐Lledó, et al.. (2021). High-Dose Cyclophosphamide and Tacrolimus as Graft-versus-Host Disease Prophylaxis for Matched and Mismatched Unrelated Donor Transplantation. Transplantation and Cellular Therapy. 27(7). 619.e1–619.e8. 16 indexed citations
15.
Pedraza, Alexandra, et al.. (2016). Biliary Complications After Liver Transplantation: Incidence, Risk Factors and Impact on Patient and Graft Survival. Transplantation Proceedings. 48(2). 665–668. 18 indexed citations
16.
Rodríguez‐Osorio, Xiana, et al.. (2015). Drug-resistant epilepsy: Definition and treatment alternatives. SHILAP Revista de lepidopterología. 30(7). 439–446. 62 indexed citations
17.
Rodríguez‐Osorio, Xiana, et al.. (2014). Epilepsia resistente a fármacos. Concepto y alternativas terapéuticas. Neurología. 30(7). 439–446. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Jeong Breakdown of academic impact, for papers by Nobuyoshi Sugiyama Breakdown of academic impact, for papers by Weihong Lin Breakdown of academic impact, for papers by Federica Ranzato Breakdown of academic impact, for papers by Muhammad Talal Alrifai Breakdown of academic impact, for papers by Alessia De Nisco Breakdown of academic impact, for papers by Marios Kaliakatsos Breakdown of academic impact, for papers by Francesco Habetswallner Breakdown of academic impact, for papers by Hideki Matsumura Breakdown of academic impact, for papers by Eleonora Mauri
Rankless by CCL
2026